The effects of l-cysteine and N-acetyl-l-cysteine on homocysteine metabolism and haemostatic markers, and on cardiac and aortic histology in subchronically methionine-treated Wistar male rats
暂无分享,去创建一个
V. Jakovljevic | D. Djuric | A. Stamenković | D. Hrnčić | S. Stanković | S. Kostić | R. Obrenović | M. Labudović-Borović | Lazar Andrejević | S. Cvetkovic | Žarko Mićovic
[1] N. Deutz,et al. Tolerance to increased supplemented dietary intakes of methionine in healthy older adults. , 2017, The American journal of clinical nutrition.
[2] Y. Benazzoug,et al. Plasma and Aorta Biochemistry and MMPs Activities in Female Rabbit Fed Methionine Enriched Diet and Their Offspring , 2017, Journal of nutrition and metabolism.
[3] Karen H. Vousden,et al. Serine and one-carbon metabolism in cancer , 2016, Nature Reviews Cancer.
[4] E. Casiglia,et al. Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial. , 2016, Journal of biological regulators and homeostatic agents.
[5] B. Wolska,et al. N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy. , 2015, American journal of physiology. Heart and circulatory physiology.
[6] T. Dar,et al. Protein N-homocysteinylation: From cellular toxicity to neurodegeneration. , 2015, Biochimica et biophysica acta.
[7] K. Frazer,et al. Brief Report: Oxidative Stress Mediates Cardiomyocyte Apoptosis in a Human Model of Danon Disease and Heart Failure , 2015, Stem cells.
[8] R. Pawlak. Is vitamin B12 deficiency a risk factor for cardiovascular disease in vegetarians? , 2015, American journal of preventive medicine.
[9] Y. Kawamata,et al. A 4-Week Toxicity Study of Methionine in Male Rats , 2015, International journal of toxicology.
[10] D. Vasudevan,et al. Elevated oxidative stress among coronary artery disease patients on statin therapy: A cross sectional study. , 2015, Indian heart journal.
[11] B. Kulah,et al. Study on relationships among deep vein thrombosis, homocysteine & related B group vitamins , 2015, Pakistan journal of medical sciences.
[12] Y. Turkoz,et al. Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats. , 2014, World journal of gastroenterology.
[13] Xiaoyan Wu,et al. N-acetylcysteine reduces oxidative stress, nuclear factor-κB activity and cardiomyocyte apoptosis in heart failure , 2014, Molecular medicine reports.
[14] X. Cai,et al. Regulation of N-acetyl cysteine on gut redox status and major microbiota in weaned piglets. , 2014, Journal of animal science.
[15] Z. Kopczyński,et al. [Hyperhomocysteinemia in patients with cardiovascular disease]. , 2014, Postepy higieny i medycyny doswiadczalnej.
[16] K. Toutouzas,et al. The effect of hyperhomocysteinemia on aortic distensibility in healthy individuals. , 2013, Nutrition.
[17] B. Banecki,et al. Homocysteine, heat shock proteins, genistein and vitamins in ischemic stroke--pathogenic and therapeutic implications. , 2012, Acta biochimica Polonica.
[18] Yingkang Shi,et al. The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE-/- mice. , 2012, Acta biochimica et biophysica Sinica.
[19] Danmei Xu,et al. Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies , 2012, Journal of Thrombosis and Thrombolysis.
[20] A. Sule,et al. Recurrent Unprovoked Venous Thromboembolism in a Young Female Patient with High Levels of Homocysteine , 2012, International Journal of Angiology.
[21] J. Lantos,et al. Effect of N-acetylcysteine treatment on the expression of leukocyte surface markers after burn injury. , 2011, Burns : journal of the International Society for Burn Injuries.
[22] U. Markert,et al. Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages , 2011, Inflammation Research.
[23] E. Tremoli,et al. Homocysteine and arterial thrombosis: Challenge and opportunity , 2010, Thrombosis and Haemostasis.
[24] S. Theocharis,et al. The neuroprotective role of l-cysteine towards the effects of short-term exposure to lanthanum on the adult rat brain antioxidant status and the activities of acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase , 2009, BioMetals.
[25] Dindagur Nagaraja,et al. Homocysteine, folate and vitamin B12 in puerperal cerebral venous thrombosis , 2008, Journal of the Neurological Sciences.
[26] F. Sofi,et al. Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. , 2008, Atherosclerosis.
[27] S. Eichinger,et al. Low vitamin B6 levels and the risk of recurrent venous thromboembolism , 2007, Haematologica.
[28] S. Kaul,et al. Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated. , 2006, Journal of the American College of Cardiology.
[29] R. Castro,et al. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overview , 2006, Journal of Inherited Metabolic Disease.
[30] C. Leitzmann,et al. German Vegan Study: Diet, Life-Style Factors, and Cardiovascular Risk Profile , 2005, Annals of Nutrition and Metabolism.
[31] M. Ribó,et al. Low levels of vitamin B12 and venous thromboembolic disease in elderly men , 2005, Journal of internal medicine.
[32] S. Lentz. Mechanisms of homocysteine‐induced atherothrombosis , 2005, Journal of thrombosis and haemostasis : JTH.
[33] H. Büller,et al. Homocysteine and markers of coagulation and endothelial cell activation , 2004, Journal of thrombosis and haemostasis : JTH.
[34] I. Rosenberg,et al. The atherogenic effect of excess methionine intake , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Szklo,et al. Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study. , 2002, Annals of epidemiology.
[36] Y. Ozkan,et al. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. , 2002, International journal of cardiology.
[37] M. Mora,et al. Antioxidant and Pro-oxidant Effect of the Thiolic Compounds N -acetyl- l -cysteine and Glutathione against Free Radical-induced Lipid Peroxidation , 2002, Free radical research.
[38] E. Falk,et al. Dietary Supplementation With Methionine and Homocysteine Promotes Early Atherosclerosis but Not Plaque Rupture in ApoE-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[39] S. Vollset,et al. Plasma Total Cysteine as a Risk Factor for Vascular Disease: The European Concerted Action Project , 2001, Circulation.
[40] W. Kisiel,et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. , 2001, The Journal of clinical investigation.
[41] M. C. Liu,et al. Blood glutathione and cysteine changes in cardiovascular disease. , 2000, The Journal of laboratory and clinical medicine.
[42] S. Vollset,et al. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. , 1999, The American journal of clinical nutrition.
[43] P. Giral,et al. Cysteine is a cardiovascular risk factor in hyperlipidemic patients. , 1999, Atherosclerosis.
[44] R. Marfella,et al. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. , 1999, JAMA.
[45] D. Jacobsen. Homocysteine and vitamins in cardiovascular disease. , 1998, Clinical chemistry.
[46] J. Selhub,et al. Homocysteine and thrombotic disease , 1997 .
[47] P. Ueland,et al. Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system. , 1996, The Journal of nutrition.
[48] P. Ueland. Homocysteine species as components of plasma redox thiol status. , 1995, Clinical chemistry.
[49] P. Lønning,et al. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[50] G. Rodgers,et al. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[51] E. Elstner,et al. Biochemical Model Reactions on the Prooxidative Activity of Homocysteine , 1993, Zeitschrift fur Naturforschung. C, Journal of biosciences.
[52] J. Sadler,et al. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. , 1991, The Journal of clinical investigation.
[53] D. Wilcken,et al. Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. , 1991, Atherosclerosis.
[54] G. Starkebaum,et al. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. , 1986, The Journal of clinical investigation.
[55] J. V. Bannister,et al. The production of free radicals during the autoxidation of cysteine and their effect on isolated rat hepatocytes. , 1982, Biochimica et biophysica acta.
[56] D. Wilcken,et al. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. , 1976, The Journal of clinical investigation.
[57] J. Bancroft,et al. Connective Tissues and Stains , 2008 .
[58] G. Maurer,et al. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction. , 2007, Thrombosis research.
[59] M. Stanton,et al. Homocysteine and cardiovascular disease , 2011 .